A systematic review of heterogeneity in outcome definition and reporting in Non-Muscle Invasive Bladder Cancer (NMIBC) effectiveness trials of adjuvant treatment after transurethral resection

Antzeko izenburuak

• A systematic review of heterogeneity in outcome definition and reporting in Non-Muscle Invasive Bladder Cancer (NMIBC) effectiveness trials of adjuvant treatment after transurethral resection
  nork: S. MacLennan, et al.
  Argitaratua: (2020-07-01)
• What are the barriers and facilitators to prescribing and instilling immediate post-operative instillations of chemotherapy in non-muscle-invasive bladder cancer (NMIBC) patients? A theory informed, multi centre qualitative study
  nork: J. Dunsmore, et al.
  Argitaratua: (2020-07-01)
• Specifying behavioural and strategy components of de-implementation efforts targeting low-value prescribing practices in secondary health care
  nork: Jennifer Dunsmore, et al.
  Argitaratua: (2024-08-01)
• Effectiveness of de-implementation strategies for low-value prescribing in secondary care: a systematic review
  nork: Jennifer Dunsmore, et al.
  Argitaratua: (2023-09-01)
• Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate
  nork: Annemieke Sobels, et al.
  Argitaratua: (2022-12-01)